BioPortfolio - KeyNeurotek AG
KeyNeurotek AG - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/25265-KeyNeurotek_A...
|
BioSpace - KeyNeurotek AG News, Search Jobs, Events
KeyNeurotek AG Receives Orphan Drug Designation Of Its Lead Compound KN38-7271 For The Treatment Of Moderate And Severe Closed Traumatic Brain Injury From ...
http://www.biospace.com/company_profile.aspx?CompanyId=62012...
|
Grünenthal - R & D
KeyNeurotek AG is currently preparing a Phase II clinical study in patients ... KeyNeurotek AG is a biotechnology company specialising in the development ...
http://www.grunenthal.com/cw/en_EN/html/cw_en_en_rand.jhtml?...
|
KeyNeurotek AG Receives Orphan Drug Designation Of Its Lead ...
KeyNeurotek AG -- Magdeburg, September 22, 2008 – KeyNeurotek Pharmaceuticals AG , a biotechnology company focused on the development and marketing of drugs ...
http://www.biospace.com/news_story.aspx?NewsEntityId=110776...
|
Juli 2003 Ein Nachrichtenmagazin aus dem ZENIT Magdeburg - frei ...
20. Aug. 2003 ... 3 Jahre KeyNeurotek AG. Die KeyNeurotek AG feierte am ... zen der KeyNeurotek AG wieder. Dr. Striggow, CEO der KeyNeurotek, re- ...
http://www.zenit-magdeburg.de/zenit/pdf/Zeitung-Juli03.pdf...
|
KeyNeurotek Pharmaceuticals Reports Breakthrough Discovery in ...
Magdeburg, July 10, 2008 - KeyNeurotek Pharmaceuticals AG, a biotechnology company focused on the development and marketing of drugs against autoimmune ...
http://www.biospace.com/news_story.aspx?NewsEntityId=102985...
|
BioPortfolio - Biocorporate Search Tissue-Based1
KeyNeurotek AG was founded in 2000 in Magdeburg, one of the leading European Centers of Neuroscience. Focused to the development of drugs for the treatment ...
http://www.bioportfolio.com/biocorporate/Tissue-Based-compan...
|
Patents - IMTM - Immune Technologies and Medicine
WO 2005004906, 08.07.2003, Fibroblasts, Hyperkeratosis, Psoriasis. WO 02053169, 02.01.2001, Neurodegeneration (jointly with KeyNeurotek AG) ...
http://www.imtm.de/news/patents/index.html...
|
Grünenthal - Press
Exclusive licensing agreement signed with KeyNeurotek AG. Aachen, Germany, 01 March 2007. The German pharmaceutical company Grünenthal has set itself ...
http://www.grunenthal.com/cw/en_EN/html/cw_en_en_press.jhtml...
|
Tau kinase inhibitors protect hippocampal synapses despite of ...
KeyNeurotek Pharmaceuticals AG, ZENIT-Technologie Park, Leipziger Strasse 44, D- 39120 Magdeburg, Germany. ina.hinners@keyneurotek.de ...
http://www.ncbi.nlm.nih.gov/pubmed/18201898...
|